"掲載中の営業日は電話応対可能な時間帯となっております。外来の受付時刻や診療開始時刻などは、診療科や曜日ごとに異なります。詳しくはホームページの外来診療担当表をご覧くださいませ。"

During the past decade, Okayama Saiseikai General Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Okayama Saiseikai General Hospital" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Haruhiko Fukuda" with 2 trials sponsored, "Kyowa Kirin Co., Ltd." with 2 trials sponsored, "Kyowa Kirin, Inc." with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Okayama Saiseikai General Hospital" #1 collaborator was "Kyowa Kirin Co., Ltd." with 2 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator, "Japan Clinical Oncology Group" with 1 trials as a collaborator and "PharmaEssentia Japan K.K." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Okayama Saiseikai General Hospital" are "Crohn's Disease" (2 trials), "Actinic Keratosis" (1 trials), "Colitis, Ulcerative" (1 trials), "Colorectal Neoplasms" (1 trials) and "Diabetic Gastroparesis" (1 trials). Many other conditions were trialed in "Okayama Saiseikai General Hospital" in a lesser frequency.

Most popular intervention types in "Okayama Saiseikai General Hospital" are "Drug" (12 trials), "Other" (3 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "KRN23" (2 trials), "Ustekinumab" (2 trials), "burosumab" (2 trials) and "5FU+l-leucovorin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Okayama Saiseikai General Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Okayama Saiseikai General Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Okayama Saiseikai General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Okayama Saiseikai General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".